Technology News and Research

RSS

NIH awards 12 research grants totaling $5 million for Tβ4 research

REGENERX BIOPHARMACEUTICALS, INC. announced today that National Institutes of Health (NIH) has awarded 12 research grants totaling over $5,000,000 for the study of Tβ4 in 2009/2010. Many of these grants will be going to collaborators with whom RegeneRx is working to understand its numerous biological activities and capabilities in medical indications, including the role of Tβ4 as an anti-inflammatory agent in tissue regeneration and its promotion of stem cell maturation.

13 Jan 2010

BDSI to discuss planned BEMA Granisetron IND with the FDA

BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI’s antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.

13 Jan 2010

Donald Danforth Plant Science Center researchers enter into research collaboration with Dow AgroSciences

Researchers working at the Donald Danforth Plant Science Center have entered into a research collaboration with Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, to study how its EXZACTTM Precision Technology can help improve the root crop cassava for millions of people living in developing countries.

13 Jan 2010

HaloSource signs agreement with WAL for the use of HaloPure disinfection cartridges in WAL’s products

HaloSource, a leading clean water company, has signed an agreement with WAL (S.A.), the Swiss-based international water filtration products company, for the use of HaloSource’s revolutionary HaloPure® disinfection cartridges in WAL’s jug and pitcher products.

13 Jan 2010

SEDLine acquires Hospira's BFM business

SEDLine™, Inc., announced today that it has acquired the brain function monitoring business of Hospira, Inc.. Privately held and backed with an investment from Masimo Corporation, SEDLine, Inc., based in Irvine, California, was formed with the mission to advance neuromonitoring technologies to improve the care of patients under anesthesia or sedation.

13 Jan 2010

NitricBio chooses Clinipace Worldwide to manage and conduct two phase 3 trials

Clinipace Worldwide, a global technology-driven clinical research organization (CRO), announced today that NitricBio has selected the company to manage and deploy multiple studies in support of medical applications of topical nitric oxide gas (gNO).

13 Jan 2010

Labor leaders confront Obama on 'Cadillac' tax proposal

Labor leaders were invited to the White House to discuss negotiations to merge the House- and Senate-passed health overhaul packages.

12 Jan 2010

Pall acquires U.S. biotechnology company

Pall Corporation, a global leader in filtration, separation and purification, today announced its acquisition of MicroReactor Technologies, Inc. (MRT), a privately held U.S. biotechnology company. MRT has developed a reliable, easy-to-use and cost-effective miniature bioreactor technology platform.

From Pall Corporation 12 Jan 2010

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

VaxInnate Corporation today announced that it has granted Indian biopharmaceutical company Biological E. Limited a license to its recombinant H1N1 pandemic swine flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India.

12 Jan 2010

Phase I clinical trial of XRX-001 for yellow fever initiated

Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.

12 Jan 2010

Enrollment complete in Dune Medical Devices' MarginProbe pivotal clinical trial

Dune Medical Devices today announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical facilities, with 18 in the US and three in Israel.

12 Jan 2010

Life Technologies to acquire AcroMetrix

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount.

12 Jan 2010

ANI launches professional development program that pairs nurses with mentors

Two nurses have won recognition as emerging leaders in the field of nursing informatics, selected by the Alliance for Nursing Informatics (ANI) to participate in a jointly supported Nursing Informatics Emerging Leaders Program.

12 Jan 2010

CBIZ acquires National Benefit Alliance

CBIZ, Inc. today announced the acquisition of National Benefit Alliance ("NBA"), an employee benefits firm located in Midvale, Utah, effective January 1, 2010.

12 Jan 2010

Nursing educators learn latest developments in nursing education at Faculty Development Institute conference

Nursing educators from across the country collaborated with industry leaders and learned the latest developments in nursing education at the 2010 Mosby's Faculty Development Institute conference earlier this month. Presented by Mosby, the three-day educational conference addressed challenges in the nursing industry from a variety of perspectives.

12 Jan 2010

Frimley Park Hospital NHS Foundation Trust implements Picis software solutions

Picis today announced that Frimley Park Hospital NHS Foundation Trust in Surrey, England has successfully implemented Picis integrated surgical, anesthesia, recovery room and critical care software solutions.

12 Jan 2010

FDA approves Celsius RMT ThermoCool catheter for use with Stereotaxis' magnetic navigation system

Stereotaxis announced that the Celsius® RMT ThermoCool® catheter has been approved by the U.S. Food and Drug Administration for use with Stereotaxis' magnetic navigation system for the treatment of Type 1 atrial flutter. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for mapping and ablation.

12 Jan 2010

Astro Pak announces the launch of new subsidiary, SixLog

Astro Pak Corporation, the U.S.'s largest precision cleaning and passivation company, today announced the launch of their new subsidiary, SixLog Corporation. SixLog provides on-site biological decontamination services utilizing proprietary iHP™ (ionized Hydrogen Peroxide) technology to a variety of industries including Life Sciences, Pharmaceutical, Healthcare, First Responders, Transportation, and Public Facilities.

12 Jan 2010

ePro custom footbeds reduce sport-induced injuries

eSoles® Custom Footbeds, the world's leading authority in the science and development of custom footbeds, announced today that eSoles Pro, Karlos Dansby, linebacker for the Arizona Cardinals® (#58), lead his team to a victory during their NFC Wild-Card playoff game while wearing his eSoles custom footbeds.

12 Jan 2010

Madison Williams launches Healthcare Investment Banking and Research business

Madison Williams and Company, an integrated capital markets and advisory firm, announced today the formal launch of a focused Healthcare Investment Banking and Research business. Madison Williams recently completed a management buyout of the principal capital markets business from Sanders Morris Harris Group in December 2009. The new firm already has a leading franchise in the Energy sector, and is quickly establishing its presence in healthcare with key new hires.

12 Jan 2010